📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Circulomics

1.1 - Company Overview

Circulomics Logo

Circulomics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of micro- and nanotechnology-driven solutions for nucleic acid sample preparation and long-read sequencing, offering Nanobind high molecular weight DNA extraction from plant, animal, and microbial samples, library preparation protocols, services for single chromosomal genome assemblies, and applications leveraging optical mapping for genome structure analysis.

Products and services

  • High Molecular Weight DNA Extraction: Circulomics produces micro- and nanotechnology-enabled methods and kits to isolate high molecular weight DNA compatible with long-read sequencing platforms and optical mapping workflows
  • Single Chromosomal Genome Assemblies: Circulomics delivers long-read-compatible services and technologies that achieve single chromosomal genome assemblies using extracted high molecular weight DNA
  • Nanobind: Circulomics architects a nanotechnology-based platform that extracts high molecular weight DNA from plant, animal, and microbial specimens for long-read sequencing and optical mapping applications

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Circulomics

Mitotyping Technologies Logo

Mitotyping Technologies

HQ: United States Website
  • Description: Provider of forensic DNA analysis services for the criminal justice system, forensic laboratories, and anthropological applications, including mitochondrial DNA testing from small samples such as 2mm hair fragments or single teeth.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mitotyping Technologies company profile →
NeoPhore Logo

NeoPhore

HQ: United Kingdom Website
  • Description: Provider of novel small molecule cancer therapies that stimulate the immune system by targeting DNA mismatch repair to induce neoantigen expression and increase immunogenicity in solid tumors, including PMS2 and MLH1 modulators that convert immune-cold tumors to hot and enhance sensitivity to immune checkpoint inhibitors, plus continuous neoantigen creation and research and development on next-generation targets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NeoPhore company profile →
Chroma Medicine Logo

Chroma Medicine

HQ: United States Website
  • Description: Provider of genetic medicines built on an epigenetic editing platform that uses programmable editors to silence, activate, or regulate multiple genes by controlling chromatin conformation; single-dose genomic medicines for precise, predictable, durable treatment; multiplex epigenetic editing to enhance allogeneic CAR T cells; and a PCSK9-targeted editor to lower cholesterol and LDL-C.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Chroma Medicine company profile →
WellGen Logo

WellGen

HQ: United States Website
  • Description: Provider of plant-based wellness products discovered and developed using nutrigenomics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full WellGen company profile →
Renova Therapeutics Logo

Renova Therapeutics

HQ: United States Website
  • Description: Provider of gene therapies for chronic diseases, focusing on cardiovascular and metabolic indications. Offerings include RT-100, a single-dose therapy to improve heart function in congestive heart failure; RT-200, a single intravenous therapy to normalize blood glucose in Type 2 Diabetes Mellitus; and paracrine gene therapy enabling systemic delivery of therapeutic genes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Renova Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Circulomics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Circulomics

2.2 - Growth funds investing in similar companies to Circulomics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Circulomics

4.2 - Public trading comparable groups for Circulomics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Circulomics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Circulomics

What does Circulomics do?

Circulomics is a provider of micro- and nanotechnology-driven solutions for nucleic acid sample preparation and long-read sequencing, offering Nanobind high molecular weight DNA extraction from plant, animal, and microbial samples, library preparation protocols, services for single chromosomal genome assemblies, and applications leveraging optical mapping for genome structure analysis.

Who are Circulomics's competitors?

Circulomics's competitors and similar companies include Mitotyping Technologies, NeoPhore, Chroma Medicine, WellGen, and Renova Therapeutics.

Where is Circulomics headquartered?

Circulomics is headquartered in United States.

How many employees does Circulomics have?

Circulomics has 1,000 employees 🔒.

When was Circulomics founded?

Circulomics was founded in 2010 🔒.

What sector and industry vertical is Circulomics in?

Circulomics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Circulomics

Who are the top strategic acquirers in Circulomics's sector and industry

Top strategic M&A buyers and acquirers in Circulomics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Circulomics?

Top strategic M&A buyers groups and sectors for Circulomics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Circulomics's sector and industry vertical

Which are the top PE firms investing in Circulomics's sector and industry vertical?

Top PE firms investing in Circulomics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Circulomics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Circulomics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Circulomics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Circulomics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Circulomics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Circulomics?

The key public trading comparables and valuation benchmarks for Circulomics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Circulomics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Circulomics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Circulomics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Circulomics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Circulomics's' sector and industry vertical?

Access recent funding rounds and capital raises in Circulomics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Circulomics

Launch login modal Launch register modal